304 related articles for article (PubMed ID: 15498571)
41. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
[TBL] [Abstract][Full Text] [Related]
43. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells.
Kobayashi H; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2004 Feb; 279(8):6371-9. PubMed ID: 14597629
[TBL] [Abstract][Full Text] [Related]
44. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C
J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
[TBL] [Abstract][Full Text] [Related]
45. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
Hazelbag S; Gorter A; Kenter GG; van den Broek L; Fleuren G
Hum Pathol; 2002 Dec; 33(12):1193-9. PubMed ID: 12514788
[TBL] [Abstract][Full Text] [Related]
47. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
48. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
49. [Influence of interferon gamma treatment on expression of TGF-beta1 and its receptors in liver fibrosis of mice with schistosomiasis japonica].
Zhang BB; Jiao YW; Cai WM; Tao J; Liu RH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec; 22(6):340-3. PubMed ID: 15830858
[TBL] [Abstract][Full Text] [Related]
50. Suppression of urokinase expression and invasion by a soybean Kunitz trypsin inhibitor are mediated through inhibition of Src-dependent signaling pathways.
Inagaki K; Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Kondo T; Kurita N; Kitanaka T; Yamada Y; Sakamoto Y; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2005 Sep; 280(36):31428-37. PubMed ID: 16002410
[TBL] [Abstract][Full Text] [Related]
51. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Kocic J; Bugarski D; Santibanez JF
Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
[TBL] [Abstract][Full Text] [Related]
52. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
[TBL] [Abstract][Full Text] [Related]
53. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
54. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
55. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
56. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
57. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
Moodley R; Snyman C; Odhav B; Bhoola KD
Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
[TBL] [Abstract][Full Text] [Related]
58. Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts.
Kim S; Lee Y; Seo JE; Cho KH; Chung JH
Cell Signal; 2008 Jul; 20(7):1313-9. PubMed ID: 18434090
[TBL] [Abstract][Full Text] [Related]
59. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
König HG; Kögel D; Rami A; Prehn JH
J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
[TBL] [Abstract][Full Text] [Related]
60. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
